1 November 2017 - 31 October 2018
Principal institution: AstraZeneca plc
Subject/journal group: All
The table to the right includes counts of all research outputs for AstraZeneca Sweden published between 1 November 2017 - 31 October 2018 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Outputs by subject (FC)
|Proceedings of the National Academy of Sciences of the United States of America||1||0.64|
Top articles by Altmetric score in current window
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability
Science Translational Medicine
Affiliated joint institutions and consortia
- AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration, Sweden
- Berzelii Center EXSELENT on Porous Materials, Stockholm University, Sweden
- KI-AZ Integrated Cardio Metabolic Centre (ICMC), Sweden
- The Esophageal Adenocarcinoma GenEtics Consortium (EAGLE), United Kingdom (UK)
- The QT Interval International GWAS Consortium (QT-IGC), United States of America (USA)
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.